04/142026

Enoxaparin Sodium Manufacturer: Jiulong’s Eco-Friendly Production for Global Anticoagulant Demand

Astheglobalburdenofthromboembolicdisorderspersists—withtheEnoxaparinSodiumAPImarketreachingUSD227millionin2024andprojectedtohitUSD300millionby2031ataCAGRof4.2％—pharmaceuticalpartnersworldwideareseek

Click to view

04/132026

Dalteparin Sodium: Jiulong’s Cost-Efficient Precision Purification for Global Anticoagulant Markets

Astheglobalburdenofthromboembolicdisordersgrows—withtheDalteparinSodiummarketprojectedtoexpandatasteadyCAGRthrough2032—pharmaceuticalpartnersworldwideareseekingareliablesourceofthiscriticallowmolecu

Click to view

04/102026

Chondroitin Sulfate Sodium Manufacturer: Jiulong’s Precision Molecular Fragment Technology for Global Joint Health Solutions

Astheglobalpopulationagesandosteoarthritisprevalencerises—affectingover300millionpeopleworldwide—thedemandforareliableChondroitinSulfateSodiumManufacturerhasbecomeincreasinglycritical.Chondroitinsul

Click to view

04/092026

Heparins Manufacturer: Jiulong’s Innovative Solutions for Global Anticoagulant Markets

Astheglobalanticoagulantmarketcontinuestoexpand—projectedtoreachUSD65.45billionby2025—thedemandforareliableHeparinsManufacturerhasbecomeincreasinglycriticalforpharmaceuticalcompanies,healthcareprovi

Click to view

04/082026

Dalteparin Sodium: Jiulong’s Precision-Manufactured Anticoagulant for Global Healthcare Needs

Astheglobalburdenofthromboembolicdisorderscontinuestorise—withtheDalteparinSodiummarketprojectedtoreachUSD1990millionin2026andgrowata6.1％CAGRthrough2032—thedemandforhigh-quality,predictablelowmolecu

Click to view

News and information